<DOC>
	<DOCNO>NCT00418509</DOCNO>
	<brief_summary>This study compare performance three combination meter dose inhalation device variability mometasone formoterol dose deliver lung healthy volunteer population</brief_summary>
	<brief_title>Study Mometasone Furoate/Formoterol Fumarate Inhalation Combination Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Healthy , male female subject age 18 65 year age ( include ) In good health confirm past medical history Female subject must either surgically sterilize least 6 month prior study participation postmenopausal ( regular menstrual bleeding least 2 year ) Body mass index ( BMI ) within range 18.5 32 kg/m2 weigh least 50 kg Able communicate well investigator , understand comply requirement study Understand sign write informed consent Smokers ( use tobacco product previous 1 year pack year history great 10 pack year ) . Female subject pregnant , lactate Treatment oral intravenous corticosteroid within 1 month first study treatment . Patients current respiratory tract infection one within 1 month prior screen . Patients history malignancy , myocardial infarction , untoward reaction sympathomimetic amine inhale medicine . Subjects current history clinically significant cardiac arrhythmia . Participation clinical investigation within 4 week prior dose longer required local regulation . Donation loss 400 mL blood within 8 week prior dose . Significant illness within two week prior dose . A past medical history clinically significant ECG abnormality . History fainting , know hypersensitivity study drug drug similar study drug . surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug may jeopardize subject case participation study , immunocompromise , include positive HIV ( ELISA Western blot ) test result , positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result , drug alcohol abuse within 12 month prior dose evidence abuse indicate laboratory assay conduct screen evaluation . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Dose proportionality</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>mometasone</keyword>
	<keyword>formoterol</keyword>
	<keyword>Healthy volunteer study</keyword>
</DOC>